Two CGD Families with a Hypomorphic Mutation in the Activation Domain of p67(phox)

Date
2014-06-30
Language
American English
Embargo Lift Date
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
OMICS Publishing Group
Abstract

STUDY BACKGROUND: Chronic granulomatous Disease (CGD) is a rare immunodeficiency caused by a defect in the leukocyte NADPH oxidase. This enzyme generates superoxide, which is needed for the killing of bacteria and fungi by phagocytic leukocytes. Most CGD patients have mutations in CYBB, the X-linked gene that encodes gp91(phox), the catalytic subunit of the leukocyte NADPH oxidase. We report here three autosomal recessive CGD patients from two families with a homozygous mutation in NCF2, the gene that encodes p67(phox), the activator subunit of the NADPH oxidase. METHODS: Leukocyte NADPH oxidase activity, expression of oxidase components and gene sequences were measured with standard methods. The mutation found in the patients' NCF2 gene was expressed as Ala202Val-p67(phox) in K562 cells to measure its effect on NADPH oxidase activity. Translocation of the mutated p67(phox) from the cytosol of the patients' neutrophils to the plasma membrane was measured by confocal microscopy and by Western blotting after membrane purification. RESULTS: The exceptional feature of the A67 CGD patients reported here is that the p.Ala202Val mutation in the activation domain of p67(phox) was clearly hypomorphic: substantial expression of p67(phox) protein was noted and the NADPH oxidase activity in the neutrophils of the patients was 20-70% of normal, dependent on the stimulus used to activate the cells. The extent of Ala202Val-p67(phox) translocation to the plasma membrane during cell activation was also stimulus dependent. Ala202Val-p67(phox) in K562 cells mediated only about 3% of normal oxidase activity compared to cells transfected with the wild-type p67(phox). CONCLUSION: The mutation found in NCF2 is the cause of the decreased NADPH oxidase activity and the (mild) clinical problems of the patients. We propose that the p.Ala202Val mutation has changed the conformation of the activation domain of p67(phox), resulting in reduced activation of gp91(phox).

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Roos, D., van Buul, J. D., Tool, A. T., Matute, J. D., Marchal, C. M., Hayee, B., … Dinauer, M. C. (2014). Two CGD Families with a Hypomorphic Mutation in the Activation Domain of p67phox. Journal of Clinical & Cellular Immunology, 5(3), 1000231.
ISSN
2155-9899
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Journal of Clinical & Cellular Immunology
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Author's manuscript
Full Text Available at
This item is under embargo {{howLong}}